Article
Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1.
Journal of medical virology - 1 Aug 2012
Amanzada Ahmad, Schneider Simon, Moriconi Federico, Lindhorst Alexander, Suermann Thomas, van Thiel David H, Mihm Sabine, Ramadori Giuliano
Abstract excerpt
IL28B genotypes and virological response within 4 weeks are predictors of sustained virological response in patients infected with chronic hepatitis C virus (HCV) genotype 1 treated with antiviral dual combination therapy. The predictive value of "early" anemia (within 4 weeks) alone or in combin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.